शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
VIMTALABSNSEVIMTA LABS LIMITED· Healthcare ServicesHighNeutral
Announced Mon, 20 Jul, 2026 · 13:38 IST

Vimta Labs Q1 FY27 results: revenue up about 12 percent, PAT up about 11 percent YoY

VIMTALABS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-5.2%Reaction day
₹558.00
prior close
₹574.10
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.6%-5.8% vs market
Healthcare Research Analytics & Technology peers, median of 5sector+1.1%-6.3% vs sector

On the reaction day the stock moved 5.8 pts less than Nifty Microcap 250 and 6.3 pts less than its Healthcare Research Analytics & Technology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-4.0
10m
-6.1
15m
-4.9
30m
-7.1
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-5.2+0.6-5.8+1.1-6.3
Next day
+7.9+0.9+6.9-0.3+8.2
2d
+4.4-0.2+4.6-1.3+5.6
3d
+1.6-0.9+2.5-2.1+3.7
4d
+1.8-0.5+2.3-2.6+4.4
5d
+5.6+0.8+4.7-1.0+6.5
1w
+7.5-0.0+7.5-0.7+8.3
15d
+16.5+3.9+12.5+3.0+13.5
1m
+15.1+4.8+10.3+15.6-0.5
2m
+10.0+5.1+4.9+4.0+6.0
3m
-13.1-1.6-11.4-10.1-3.0
UpDownMarket · Nifty Microcap 250Sector · Healthcare Research Analytics & Technology peers, median of 5Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Vimta Labs posted Q1 FY27 revenue of INR 1,090.74 million, up about 12 percent YoY from INR 975.64 million. Profit after tax rose about 11 percent to INR 210.42 million from INR 188.94 million. EPS stood at INR 4.71 versus INR 4.25. The board also approved ESOP grants of 40,500 options to employees. Auditor issued an unmodified limited review report.

Likely market impact

Steady double-digit revenue and profit growth with a clean auditor report. Employee stock option grant noted. Generally positive for shareholders.